ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.563,45
0,36%
S&P 500
6.114,63
-0,01%
Dow Jones
44.546,08
-0,37%
Euro vs US Dollar
1,04764
-0,18%
Bitcoin
96.070,90
-0,06%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Eli Lilly and Co (LLY)

  7. Eli Lilly and Co (LLY) News

LLY

Eli Lilly (LLY)

Eli Lilly and Co
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:LLY
DatumZeitQuelleÜberschriftSymbolFirma
13/02/202521h43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
12/02/202522h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
12/02/202522h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
12/02/202522h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
12/02/202522h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
12/02/202522h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
12/02/202522h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
12/02/202522h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
12/02/202522h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
12/02/202522h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
12/02/202522h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
12/02/202521h28Edgar (US Regulatory)Form 8-K - Current reportNYSE:LLYEli Lilly and Co
11/02/202522h49Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:LLYEli Lilly and Co
10/02/202523h21Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:LLYEli Lilly and Co
10/02/202517h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
10/02/202514h15Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:LLYEli Lilly and Co
07/02/202522h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
07/02/202514h52Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:LLYEli Lilly and Co
07/02/202512h45PR Newswire (US)Most patients on Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease achieved sustained clinical remission and endoscopic response at two yearsNYSE:LLYEli Lilly and Co
06/02/202522h04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
06/02/202517h30IH Market NewsEli Lilly Stock Price Rises As Profits Exceed ExpectationsNYSE:LLYEli Lilly and Co
06/02/202513h05Edgar (US Regulatory)Form 8-K - Current reportNYSE:LLYEli Lilly and Co
06/02/202512h45PR Newswire (US)Lilly reports full Q4 2024 financial results and provides 2025 guidanceNYSE:LLYEli Lilly and Co
04/02/202522h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
04/02/202522h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
04/02/202522h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
04/02/202522h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
04/02/202522h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
04/02/202522h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
04/02/202522h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
 Showing the most relevant articles for your search:NYSE:LLY

Kürzlich von Ihnen besucht

TG
ALV
Allianz
NYSE
KO
Coca Cola
COIN
DOGEUSD
Dogecoin
DBI
TDXP
Tec DAX
TG
RHM
Rheinmetall
USOTC
BASFY
BASF (QX)
CCOM
SILVER
SILVER
DBI
DAX
DAX
CCOM
US100
US Tech 100
TG
BAS
BASF
TG
NOV
Novo Nordisk
USOTC
RHHBY
Roche (QX)
NYSE
MRK
Merck
NYSE
XOM
Exxon Mobil
TG
D7G
Nel ASA
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten